Cardiometabolic

EnteroSatys / Satylia

EnteroSatys Metabolism is based on Hafnia alvei combined in a patented formulation with zinc and chromium, for the EU claim contributes to the normal metabolism of macronutrients (glucids and lipids). It is a premium, highly stable (36 months at room temperature) probiotic available for distribution in many countries.

EnteroSatys / Satylia Read More »

Probi Digestis®

Probi Digestis® is based on the probiotic strain Lactiplantibacillus plantarum 299v (LP299V®). LP299V® has been documented within several areas, all related to health benefits in the gut. It is described in more than 200 scientific publications and has been subject to more than 70 clinical studies. Clinical results have been shown within areas reaching from

Probi Digestis® Read More »

MetSyn

MetSyn is a probiotic complex by SynBalance, specifically designed for metabolic syndrome.It has been tested in a randomized, double-blind, controlled clinical trial on 60 subjects diagnosed with metabolic syndrome. After 14 days of run-in, in which subjects were asked to improve their lifestyle, the probiotic and placebo supplements were administered for 2 months. Patients were

MetSyn Read More »

Lactobacillus salivarius I 1794

Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL / HDL ratio. Reduces the release of type 2 cytokines, induces an improvement in the th1 / th2 ratio. Deposited at

Lactobacillus salivarius I 1794 Read More »

Lactobacillus paracasei I 1688

Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL / HDL ratio. Reduces the release of type 2 cytokines, induces an improvement in the th1 / th2 ratio. Deposited at

Lactobacillus paracasei I 1688 Read More »

Hafnia alvei HA4597

Hafnia alvei is the first precision probiotic developed based on a target-based approach and a screening for strains producing ClpB, a protein mimicking alpha-MSH and activating the signals of satiety. Its mechanism of action and demonstration in efficacy in mice and humans make it a uniquely positioned, innovative next-gen probiotic for weight management.

Hafnia alvei HA4597 Read More »

Scroll to Top
Browse companies by type
Brought to you by